RxNorm Semantic Concepts Index - 400
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "400".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 400 | Agglutinin | Designated preferred name (PT) | NO | |
| RxCUI: 400 | Agglutinin | Full form of descriptor (FN) | NO | |
| RxCUI: 4000 | Epoxide hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 4000 | Epoxide hydratase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 4000 | Epoxide hydratase | Designated preferred name (PT) | NO | |
| RxCUI: 4000 | Epoxide hydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 400008 | insulin glulisine | Designated preferred name (PT) | YES | |
| RxCUI: 400008 | insulin glulisine | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 400008 | insulin glulisine | Full form of descriptor (FN) | YES | |
| RxCUI: 400008 | insulin glulisine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 400008 | insulin glulisine | Designated preferred name (PT) | YES | |
| RxCUI: 400008 | insulin glulisine | Full form of descriptor (FN) | YES | |
| RxCUI: 40001 | zopiclone | Full form of descriptor (FN) | NO | |
| RxCUI: 40001 | zopiclone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 40001 | zopiclone | Designated preferred name (PT) | NO | |
| RxCUI: 40001 | zopiclone | Full form of descriptor (FN) | NO | |
| RxCUI: 40001 | zopiclone | Designated preferred name (PT) | NO | |
| RxCUI: 40003 | zotepine | Full form of descriptor (FN) | NO | |
| RxCUI: 40003 | zotepine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 40003 | zotepine | Designated preferred name (PT) | NO | |
| RxCUI: 40003 | zotepine | Full form of descriptor (FN) | NO | |
| RxCUI: 40003 | zotepine | Designated preferred name (PT) | NO | |
| RxCUI: 40028 | Anistreplase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 40028 | Anistreplase | Designated preferred name (PT) | NO | |
| RxCUI: 40028 | Anistreplase | Full form of descriptor (FN) | NO | |
| RxCUI: 40028 | Anistreplase | Designated preferred name (PT) | NO | |
| RxCUI: 40028 | Anistreplase | Full form of descriptor (FN) | NO | |
| RxCUI: 40036 | Benzethonium chloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 40036 | Benzethonium chloride | Designated preferred name (PT) | YES | |
| RxCUI: 40036 | Benzethonium chloride | Full form of descriptor (FN) | YES | |
| RxCUI: 40048 | Carboplatin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 40048 | Carboplatin | Designated preferred name (PT) | YES | |
| RxCUI: 40048 | Carboplatin | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 40048 | Carboplatin | Full form of descriptor (FN) | YES | |
| RxCUI: 40048 | Carboplatin | Designated preferred name (PT) | YES | |
| RxCUI: 40048 | Carboplatin | Full form of descriptor (FN) | YES | |
| RxCUI: 40049 | CD11a - cluster of differentiation antigen 11a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 40049 | CD11a - cluster of differentiation antigen 11a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 40049 | CD11a - cluster of differentiation antigen 11a | Designated preferred name (PT) | NO | |
| RxCUI: 40049 | CD11a - cluster of differentiation antigen 11a | Full form of descriptor (FN) | NO | |
| RxCUI: 400513 | acidulated phosphate fluoride 0.0123 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400517 | oxygen 87 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400518 | helium 21 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400519 | helium 300 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400520 | oxygen 700 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400521 | helium 40 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400522 | oxygen 60 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400523 | helium 60 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400524 | helium 70 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400525 | helium 75 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400526 | oxygen 25 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400531 | oxygen 93 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400533 | nitrogen 99.2 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400534 | carbon dioxide 10.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400535 | helium 89.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400536 | carbon dioxide / helium Gas for Inhalation | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 400537 | helium 99.5 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400538 | helium 99.9 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400539 | chloramphenicol / resorcinol / salicylic acid Topical Lotion | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 400540 | nitrous oxide 90 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 400542 | nitrous oxide 100 % | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 400546 | 1-chlorohexane halidohydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 400546 | 1-chlorohexane halidohydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 400546 | 1-chlorohexane halidohydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 400560 | Levemir | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 400565 | Eserine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 400569 | Fibrinogen Paris I | Designated preferred name (PT) | NO | |
| RxCUI: 400569 | Fibrinogen Paris I | Full form of descriptor (FN) | NO | |
| RxCUI: 400571 | Elase | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 400601 | Fibrinogen Naples | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 40065 | Cytokine | Designated preferred name (PT) | NO | |
| RxCUI: 40065 | Cytokine | Full form of descriptor (FN) | NO | |
| RxCUI: 40065 | Cytokine | Designated preferred name (PT) | NO | |
| RxCUI: 40065 | Cytokine | Full form of descriptor (FN) | NO | |
| RxCUI: 400674 | Product containing dexbrompheniramine and pseudoephedrine (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 400674 | Product containing dexbrompheniramine and pseudoephedrine (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 400674 | Product containing dexbrompheniramine and pseudoephedrine (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 40068 | dextran sulfate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 40070 | D-thyroxine sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 40070 | D-thyroxine sodium | Designated preferred name (PT) | NO | |
| RxCUI: 40070 | D-thyroxine sodium | Full form of descriptor (FN) | NO | |
| RxCUI: 40070 | D-thyroxine sodium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |